FDA Inspection 947903 — Centrient Pharmaceuticals Spain S.A.
The FDA completed an inspection of Centrient Pharmaceuticals Spain S.A. on September 25, 2015 in Santa Perpetua De Mogoda. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 25, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Santa Perpetua De Mogoda (Spain)